To measure serum prolactin levels in Obese patients with type 2 Diabetes mellitus and to infer its association with cardiovascular complications.
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: E116- Type 2 diabetes mellitus with other specified complicationsHealth Condition 3: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2024/08/072382
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients more than 18 years of age.
2. Patients with Type 2 Diabetes mellitus and Obesity.
Exclusion Criteria
1. Pregnant females.
2. Patients less than 18 years of age.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the levels of Prolactin in Obese Type 2 Diabetes mellitus patients.Timepoint: Prolactin levels will be assessed during the first visit of the patient.
- Secondary Outcome Measures
Name Time Method To determine the association between Prolactin levels & carotid intimal medial thickness in Obese patients with Type 2 Diabetes mellitus.Timepoint: Prolactin levels & carotid intima media thickness shall be measured on the first visit. Each patient prolactin level will be correlated with their carotid intima & medial thickness on the first visit itself. No follow up is needed further in this study.